Zhengye Biotechnology Holding (ZYBT) Assets Average (2024 - 2025)
Zhengye Biotechnology Holding's (ZYBT) quarterly Assets Average came in at $66.0 million in Q4 2025, down 4.43% year-over-year from $69.0 million in Q4 2024, and down 5.12% quarter-over-quarter from $69.6 million in Q2 2025.
Powered by 
Analysis
Zhengye Biotechnology Holding (ZYBT) Assets Average (2024 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Assets Average for 2 consecutive years, with $66.0 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Assets Average fell 4.43% year-over-year to $66.0 million in Q4 2025; TTM through Dec 2025 was $66.0 million, a 4.43% decrease from a year earlier, with the FY2025 full-year figure at $65.0 million, down 5.12% from the prior year.
- Assets Average was $66.0 million for Q4 2025 at Zhengye Biotechnology Holding, down from $69.6 million in the prior quarter.
- Over five years, Assets Average peaked at $69.6 million in Q2 2025 and troughed at $66.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.38 Bn | 40.19 Bn | 779.09 Mn | 3.41 Bn |
| 2 | Zoetis | 30.53 Bn | 28.85 Bn | 1.05 Bn | 15.12 Bn |
| 3 | Elanco Animal Health | 11.56 Bn | 11.03 Bn | 798.00 Mn | 13.39 Bn |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | 1.47 Bn |
| 5 | Immucell | 89.38 Mn | 80.52 Mn | 2.44 Mn | 44.58 Mn |
| 6 | Zhengye Biotechnology Holding | 76.71 Mn | 69.61 Mn | - | 65.99 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 565,609.50 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 65.99 Mn |
| Jun 30, 2025 | 69.56 Mn |
| Dec 31, 2024 | 69.05 Mn |